Lazard Asset Management LLC Abb Vie Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 141,574 shares of ABBV stock, worth $24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
141,574
Previous 277,237 48.93%
Holding current value
$24 Million
Previous $47.6 Million 41.2%
% of portfolio
0.04%
Previous 0.07%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$163.84 - $199.33 $22.2 Million - $27 Million
-135,663 Reduced 48.93%
141,574 $28 Million
Q2 2024

Aug 14, 2024
SELL
$154.79 - $180.76 $25.3 Million - $29.5 Million
-163,374 Reduced 37.08%
277,237 $47.6 Million
Q1 2024

May 14, 2024
SELL
$159.82 - $182.1 $7.62 Million - $8.68 Million
-47,659 Reduced 9.76%
440,611 $80.2 Million
Q4 2023

Feb 14, 2024
BUY
$137.6 - $154.97 $40.3 Million - $45.4 Million
293,222 Added 150.33%
488,270 $75.7 Million
Q3 2023

Nov 14, 2023
BUY
$133.59 - $154.65 $12.7 Million - $14.7 Million
95,057 Added 95.07%
195,048 $29.1 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $4.83 Million - $6.01 Million
36,438 Added 57.33%
99,991 $13.5 Million
Q1 2023

May 15, 2023
SELL
$144.61 - $166.54 $224,290 - $258,303
-1,551 Reduced 2.38%
63,553 $10.1 Million
Q4 2022

Feb 14, 2023
BUY
$138.31 - $165.87 $646,737 - $775,608
4,676 Added 7.74%
65,104 $10.5 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $4.08 Million - $4.68 Million
-30,427 Reduced 33.49%
60,428 $8.11 Million
Q2 2022

Aug 09, 2022
BUY
$137.62 - $174.96 $4.44 Million - $5.65 Million
32,278 Added 55.1%
90,855 $13.9 Million
Q1 2022

May 13, 2022
SELL
$131.98 - $163.75 $1.22 Million - $1.51 Million
-9,206 Reduced 13.58%
58,577 $9.49 Million
Q4 2021

Feb 09, 2022
BUY
$107.43 - $135.93 $59,945 - $75,848
558 Added 0.83%
67,783 $9.18 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $397,191 - $450,871
-3,733 Reduced 5.26%
67,225 $7.25 Million
Q2 2021

Aug 12, 2021
SELL
$105.21 - $117.21 $2.65 Million - $2.95 Million
-25,149 Reduced 26.17%
70,958 $7.99 Million
Q1 2021

May 14, 2021
SELL
$102.3 - $112.62 $76.5 Million - $84.2 Million
-747,915 Reduced 88.61%
96,107 $10.4 Million
Q4 2020

Feb 11, 2021
SELL
$80.49 - $108.67 $667,423 - $901,091
-8,292 Reduced 0.97%
844,022 $90.4 Million
Q3 2020

Nov 13, 2020
BUY
$85.91 - $100.83 $8.91 Million - $10.5 Million
103,677 Added 13.85%
852,314 $74.7 Million
Q2 2020

Aug 13, 2020
BUY
$73.37 - $98.18 $5.62 Million - $7.52 Million
76,631 Added 11.4%
748,637 $73.5 Million
Q1 2020

May 14, 2020
BUY
$64.5 - $97.79 $4.55 Million - $6.9 Million
70,531 Added 11.73%
672,006 $51.2 Million
Q4 2019

Feb 13, 2020
BUY
$72.13 - $90.25 $5.37 Million - $6.72 Million
74,471 Added 14.13%
601,475 $53.3 Million
Q3 2019

Nov 14, 2019
BUY
$62.98 - $75.72 $3.76 Million - $4.52 Million
59,734 Added 12.78%
527,004 $39.9 Million
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $11.2 Million - $14.3 Million
170,018 Added 57.2%
467,270 $34 Million
Q1 2019

May 13, 2019
BUY
$77.14 - $90.79 $20.7 Million - $24.4 Million
268,887 Added 947.95%
297,252 $24 Million
Q4 2018

Feb 13, 2019
SELL
$77.85 - $96.01 $8.87 Million - $10.9 Million
-113,898 Reduced 80.06%
28,365 $2.61 Million
Q3 2018

Nov 13, 2018
BUY
$88.91 - $98.84 $2.69 Million - $2.99 Million
30,211 Added 26.96%
142,263 $13.5 Million
Q2 2018

Aug 13, 2018
SELL
$89.78 - $106.23 $4.13 Million - $4.89 Million
-46,042 Reduced 29.12%
112,052 $10.4 Million
Q1 2018

Aug 28, 2019
SELL
$92.01 - $123.21 $98,542 - $131,957
-1,071 Reduced 0.67%
158,094 $15 Million
Q1 2018

May 14, 2018
SELL
$92.01 - $123.21 $40.7 Million - $54.5 Million
-442,491 Reduced 73.55%
159,165 $15.1 Million
Q4 2017

Aug 28, 2019
SELL
$89.56 - $98.21 $167,925 - $184,143
-1,875 Reduced 0.31%
601,656 $58.2 Million
Q4 2017

Feb 13, 2018
BUY
$89.56 - $98.21 $10.5 Million - $11.5 Million
116,797 Added 24.0%
603,531 $58.4 Million
Q3 2017

Nov 13, 2017
BUY
$69.85 - $89.22 $11 Million - $14.1 Million
157,532 Added 47.85%
486,734 $43.3 Million
Q2 2017

Aug 19, 2019
BUY
N/A
32,062 Added 10.79%
329,202 $23.9 Million
Q1 2017

Aug 13, 2019
BUY
N/A
196,832 Added 196.23%
297,140 $19.4 Million
Q4 2016

Jul 30, 2019
SELL
N/A
-78,726 Reduced 43.97%
100,308 $6.28 Million
Q3 2016

Aug 07, 2019
BUY
N/A
45,087 Added 33.66%
179,034 $11.3 Million
Q2 2016

Jul 29, 2019
BUY
N/A
125,931 Added 1571.0%
133,947 $8.29 Million
Q1 2016

Jul 25, 2019
BUY
N/A
1,869 Added 30.41%
8,016 $457,000
Q4 2015

Jul 24, 2019
SELL
N/A
-2,192 Reduced 26.29%
6,147 $364,000
Q3 2015

Jul 15, 2019
BUY
N/A
1,339 Added 19.13%
8,339 $453,000
Q2 2015

Jul 08, 2019
SELL
N/A
-153,149 Reduced 95.63%
7,000 $470,000
Q4 2014

Aug 29, 2019
BUY
N/A
160,149
160,149 $10.5 Million

Others Institutions Holding ABBV

# of Institutions
3,863
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email